Evaluating the cost-benefit profile of CPI stem cell therapy necessitates a comprehensive examination. Supporters often stress the opportunity for substantial therapeutic gains, especially in diseases where conventional therapies have proven ineffective. However, this is to assess the significant financial burden associated with CPI stem cell thera